leisure time -WSS

leisure time

author：focus 2025-09-28 02:32:28 - browse：74

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Readout Newsletter: Amylyx, Aurinia, and IQVIA

WSS

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

The drug industry sees a key ally in the Senate prevail

A cyberattack has disrupted hospitals and health care in several states

ER docs worry over extreme heat as a 'mass casualty event'

Too many hospitalized Covid

AMAs digital advisors table RPM coding reform proposal, again

focus

leisure time

hotspot

At least 13 dead in Texas as scorching temps continue

Too many hospitalized Covid

Medical records are filled with copy

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Wildfire smoke exposes gaps in outdoor worker protections

AMAs digital advisors table RPM coding reform proposal, again

Trump demands the U.S. pay no more for drugs than other countries … again

Too many hospitalized Covid

New air purifier tech could be key to improving indoor air quality

Verily hires former Apple Health leader as chief scientific officer

explore

ProMED, early warning system on disease outbreaks, in peril

Biden calls for immediate release of Niger's president amid apparent coup

2 US Navy sailors arrested for allegedly spying for China

Abbott's new heart device gets FDA advisory panel nod

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Long Covid research funding gets a major boost from NIH

hotspot

focus

hotspot

leisure time